APO Research
Talk to an analyst

APO RESEARCH · REPORT

Marek's Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Marek's Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchMarek's Disease Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Marek's Disease Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Marek's Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marek's Disease Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Marek's Disease Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Marek's Disease Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Marek's Disease Vaccine include Boehringer Ingelheim, Ceva, Merial, Zoetis, Beijing Huadu Shihua Biological Products Co., Ltd., Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Guangxi Lichengdong Biological Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Marek's Disease Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Marek's Disease Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Marek's Disease Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Marek's Disease Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Marek's Disease Vaccine Segment by Company

Boehringer Ingelheim

Ceva

Merial

Zoetis

Beijing Huadu Shihua Biological Products Co., Ltd.

Guangdong Wen's Dahuanong Biotechnology Co., Ltd.

Guangxi Lichengdong Biological Co., Ltd.

Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Merck

Ruipu Biopharmaceutical Co., Ltd.

Marek's Disease Vaccine Segment by Type

Bivalent Vaccine

Monovalent Vaccine

Marek's Disease Vaccine Segment by Application

Veterinary Pharmacy

Online Sale

Others

Marek's Disease Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marek's Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marek's Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marek's Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Marek's Disease Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Marek's Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Marek's Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Marek's Disease Vaccine Industry Trends Table 2. Marek's Disease Vaccine Industry Drivers Table 3. Marek's Disease Vaccine Industry Opportunities and Challenges Table 4. Marek's Disease Vaccine Industry Restraints Table 5. Global Marek's Disease Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Marek's Disease Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Marek's Disease Vaccine Sales by Manufacturers (K Doses) & (2021-2026) Table 8. Global Marek's Disease Vaccine Sales Market Share by Manufacturers Table 9. Global Marek's Disease Vaccine Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global Marek's Disease Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Marek's Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Marek's Disease Vaccine Manufacturers, Product Type & Application Table 13. Global Marek's Disease Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Marek's Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Bivalent Vaccine Table 17. Major Manufacturers of Monovalent Vaccine Table 18. Global Marek's Disease Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 19. Global Marek's Disease Vaccine Sales by Type (2021-2026) & (K Doses) Table 20. Global Marek's Disease Vaccine Sales by Type (2027-2032) & (K Doses) Table 21. Global Marek's Disease Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Marek's Disease Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Marek's Disease Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Doses) Table 24. Global Marek's Disease Vaccine Revenue by Type (2021-2026) & (K Doses) Table 25. Global Marek's Disease Vaccine Revenue by Type (2027-2032) & (K Doses) Table 26. Global Marek's Disease Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Marek's Disease Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Veterinary Pharmacy Table 29. Major Manufacturers of Online Sale Table 30. Major Manufacturers of Others Table 31. Global Marek's Disease Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 32. Global Marek's Disease Vaccine Sales by Application (2021-2026) & (K Doses) Table 33. Global Marek's Disease Vaccine Sales by Application (2027-2032) & (K Doses) Table 34. Global Marek's Disease Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Marek's Disease Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Marek's Disease Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Doses) Table 37. Global Marek's Disease Vaccine Revenue by Application (2021-2026) & (K Doses) Table 38. Global Marek's Disease Vaccine Revenue by Application (2027-2032) & (K Doses) Table 39. Global Marek's Disease Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Marek's Disease Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Marek's Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 42. Global Marek's Disease Vaccine Sales by Region (2021-2026) & (K Doses) Table 43. Global Marek's Disease Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Marek's Disease Vaccine Sales Forecasted by Region (2027-2032) & (K Doses) Table 45. Global Marek's Disease Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Marek's Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 47. North America Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 48. North America Marek's Disease Vaccine Sales by Country (2027-2032) & (K Doses) Table 49. Europe Marek's Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 50. Europe Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 51. Europe Marek's Disease Vaccine Sales by Country (2027-2032) & (K Doses) Table 52. Asia Pacific Marek's Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 53. Asia Pacific Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 54. Asia Pacific Marek's Disease Vaccine Sales by Country (2027-2032) & (K Doses) Table 55. South America, Middle East and Africa Marek's Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 56. South America, Middle East and Africa Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 57. South America, Middle East and Africa Marek's Disease Vaccine Sales by Country (2027-2032) & (K Doses) Table 58. Global Marek's Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Marek's Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Marek's Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Marek's Disease Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Marek's Disease Vaccine Revenue Market Share by Region (2027-2032) Table 63. Boehringer Ingelheim Company Information Table 64. Boehringer Ingelheim Business Overview Table 65. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio Table 67. Boehringer Ingelheim Recent Development Table 68. Ceva Company Information Table 69. Ceva Business Overview Table 70. Ceva Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Ceva Marek's Disease Vaccine Product Portfolio Table 72. Ceva Recent Development Table 73. Merial Company Information Table 74. Merial Business Overview Table 75. Merial Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merial Marek's Disease Vaccine Product Portfolio Table 77. Merial Recent Development Table 78. Zoetis Company Information Table 79. Zoetis Business Overview Table 80. Zoetis Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Zoetis Marek's Disease Vaccine Product Portfolio Table 82. Zoetis Recent Development Table 83. Beijing Huadu Shihua Biological Products Co., Ltd. Company Information Table 84. Beijing Huadu Shihua Biological Products Co., Ltd. Business Overview Table 85. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 87. Beijing Huadu Shihua Biological Products Co., Ltd. Recent Development Table 88. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information Table 89. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Business Overview Table 90. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 92. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Development Table 93. Guangxi Lichengdong Biological Co., Ltd. Company Information Table 94. Guangxi Lichengdong Biological Co., Ltd. Business Overview Table 95. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 97. Guangxi Lichengdong Biological Co., Ltd. Recent Development Table 98. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information Table 99. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview Table 100. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 102. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development Table 103. Merck Company Information Table 104. Merck Business Overview Table 105. Merck Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Merck Marek's Disease Vaccine Product Portfolio Table 107. Merck Recent Development Table 108. Ruipu Biopharmaceutical Co., Ltd. Company Information Table 109. Ruipu Biopharmaceutical Co., Ltd. Business Overview Table 110. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 112. Ruipu Biopharmaceutical Co., Ltd. Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Marek's Disease Vaccine Distributors List Table 116. Marek's Disease Vaccine Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Marek's Disease Vaccine Product Image Figure 2. Global Marek's Disease Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marek's Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Marek's Disease Vaccine Sales (2021-2032) & (K Doses) Figure 5. Global Marek's Disease Vaccine Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Marek's Disease Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Bivalent Vaccine Image Figure 9. Monovalent Vaccine Image Figure 10. Global Marek's Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 11. Global Marek's Disease Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Marek's Disease Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Marek's Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 14. Global Marek's Disease Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Marek's Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Veterinary Pharmacy Image Figure 17. Online Sale Image Figure 18. Others Image Figure 19. Global Marek's Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 20. Global Marek's Disease Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Marek's Disease Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Marek's Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 23. Global Marek's Disease Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Marek's Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 26. North America Marek's Disease Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 28. Canada Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 29. Mexico Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 30. Europe Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 31. Europe Marek's Disease Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 33. France Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 34. U.K. Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 35. Italy Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 36. Netherlands Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 37. Asia Pacific Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 38. Asia Pacific Marek's Disease Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 40. Japan Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 41. South Korea Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 42. Southeast Asia Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 43. India Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 44. Australia Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 45. South America, Middle East and Africa Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 46. South America, Middle East and Africa Marek's Disease Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 48. South Africa Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 49. Saudi Arabia Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 50. Turkey Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 51. Argentina Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 52. UAE Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 53. Egypt Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 54. Chile Marek's Disease Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 55. Global Marek's Disease Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Marek's Disease Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Marek's Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Marek's Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Marek's Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Marek's Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Marek's Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Marek's Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Marek's Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Marek's Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Marek's Disease Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Marek's Disease Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Bivalent Vaccine
  • Monovalent Vaccine
Applications
  • Veterinary Pharmacy
  • Online Sale
  • Others
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Merial
  • Zoetis
  • Beijing Huadu Shihua Biological Products Co., Ltd.
  • Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
  • Guangxi Lichengdong Biological Co., Ltd.
  • Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  • Merck
  • Ruipu Biopharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Marek's Disease Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Marek's Disease Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Marek's Disease Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Marek's Disease Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Marek's Disease Vaccine Market Dynamics
  1. 2.1 Marek's Disease Vaccine Industry Trends
  2. 2.2 Marek's Disease Vaccine Industry Drivers
  3. 2.3 Marek's Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Marek's Disease Vaccine Industry Restraints
3 Marek's Disease Vaccine Market by Manufacturers
  1. 3.1 Global Marek's Disease Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Marek's Disease Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Marek's Disease Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Marek's Disease Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Marek's Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Marek's Disease Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Marek's Disease Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Marek's Disease Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Marek's Disease Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Marek's Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Marek's Disease Vaccine Market by Type
  1. 4.1 Marek's Disease Vaccine Type Introduction
  2. 4.1.1 Bivalent Vaccine
  3. 4.1.2 Monovalent Vaccine
  4. 4.2 Global Marek's Disease Vaccine Sales by Type
  5. 4.2.1 Global Marek's Disease Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Marek's Disease Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Marek's Disease Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Marek's Disease Vaccine Revenue by Type
  9. 4.3.1 Global Marek's Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Marek's Disease Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Marek's Disease Vaccine Revenue Market Share by Type (2021-2032)
5 Marek's Disease Vaccine Market by Application
  1. 5.1 Marek's Disease Vaccine Application Introduction
  2. 5.1.1 Veterinary Pharmacy
  3. 5.1.2 Online Sale
  4. 5.1.3 Others
  5. 5.2 Global Marek's Disease Vaccine Sales by Application
  6. 5.2.1 Global Marek's Disease Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Marek's Disease Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Marek's Disease Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Marek's Disease Vaccine Revenue by Application
  10. 5.3.1 Global Marek's Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Marek's Disease Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Marek's Disease Vaccine Revenue Market Share by Application (2021-2032)
6 Global Marek's Disease Vaccine Sales by Region
  1. 6.1 Global Marek's Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Marek's Disease Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Marek's Disease Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Marek's Disease Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Marek's Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Marek's Disease Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Marek's Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Marek's Disease Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Marek's Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Marek's Disease Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Marek's Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Marek's Disease Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Marek's Disease Vaccine Revenue by Region
  1. 7.1 Global Marek's Disease Vaccine Revenue by Region
  2. 7.1.1 Global Marek's Disease Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Marek's Disease Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Marek's Disease Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Marek's Disease Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Marek's Disease Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Marek's Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Marek's Disease Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Marek's Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Marek's Disease Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Marek's Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Marek's Disease Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Marek's Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva
  8. 8.2.1 Ceva Company Information
  9. 8.2.2 Ceva Business Overview
  10. 8.2.3 Ceva Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Marek's Disease Vaccine Product Portfolio
  12. 8.2.5 Ceva Recent Developments
  13. 8.3 Merial
  14. 8.3.1 Merial Company Information
  15. 8.3.2 Merial Business Overview
  16. 8.3.3 Merial Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merial Marek's Disease Vaccine Product Portfolio
  18. 8.3.5 Merial Recent Developments
  19. 8.4 Zoetis
  20. 8.4.1 Zoetis Company Information
  21. 8.4.2 Zoetis Business Overview
  22. 8.4.3 Zoetis Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zoetis Marek's Disease Vaccine Product Portfolio
  24. 8.4.5 Zoetis Recent Developments
  25. 8.5 Beijing Huadu Shihua Biological Products Co., Ltd.
  26. 8.5.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
  27. 8.5.2 Beijing Huadu Shihua Biological Products Co., Ltd. Business Overview
  28. 8.5.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio
  30. 8.5.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments
  31. 8.6 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
  32. 8.6.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
  33. 8.6.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Business Overview
  34. 8.6.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio
  36. 8.6.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments
  37. 8.7 Guangxi Lichengdong Biological Co., Ltd.
  38. 8.7.1 Guangxi Lichengdong Biological Co., Ltd. Company Information
  39. 8.7.2 Guangxi Lichengdong Biological Co., Ltd. Business Overview
  40. 8.7.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio
  42. 8.7.5 Guangxi Lichengdong Biological Co., Ltd. Recent Developments
  43. 8.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  44. 8.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
  45. 8.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
  46. 8.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio
  48. 8.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Marek's Disease Vaccine Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Ruipu Biopharmaceutical Co., Ltd.
  56. 8.10.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio
  60. 8.10.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Marek's Disease Vaccine Value Chain Analysis
  2. 9.1.1 Marek's Disease Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Marek's Disease Vaccine Production Mode & Process
  6. 9.2 Marek's Disease Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Marek's Disease Vaccine Distributors
  9. 9.2.3 Marek's Disease Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst